Phase I/II study of imatinib mesylate for recurrent malignant gliomas : North american braintumor consortium study 99-08

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2006, Vol.12 (16), p.4899-4907
Main Authors: WEN, Patrick Y, YUNG, W. K. Alfred, GILBERT, Mark, SUSAN CHANG, JUNCK, Larry, SCHIFF, David, LIEBERMAN, Frank, FINE, Howard A, MEHTA, Minesh, ROBINS, H. Ian, DEANGELIS, Lisa M, GROVES, Morris D, LAMBORN, Kathleen R, PUDUVALLI, Vinay K, LEVIN, Victor, CONRAD, Charles, MAHER, Elizabeth A, ALDAPE, Kenneth, HAYES, Michael, LETVAK, Laurie, EGORIN, Merrill J, CAPDEVILLE, Renaud, KAPLAN, Richard, DAHIA, Patricia L, MURGO, Anthony J, STILES, Charles, PRADOS, Michael D, YANFENG WANG, BIN PENG, ABREY, Lauren E, RAIZER, Jeffrey, CLOUGHESY, Timothy F, FINK, Karen
Format: Article
Language:English
Subjects:
Antineoplastic agents
Biological and medical sciences
Medical sciences
Neurology
Pharmacology. Drug treatments
Tumors of the nervous system. Phacomatoses
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1078-0432
1557-3265